Title
Angiotensin-Converting Enzyme (ACE) genetic variation and longevity in Peruvian older people: a cross-sectional study
Date Issued
02 April 2020
Access level
open access
Resource Type
journal article
Publisher(s)
Taylor and Francis Ltd
Abstract
Background: Some studies have suggested that the insertion(I)/deletion(D) polymorphism of the Angiotensin-Converting Enzyme (ACE) gene may be associated with human longevity, especially in centenarians. However, this association is still controversial. Besides, there have been no studies in Peruvians. Aim: To describe the age distribution of the ACE polymorphism in a convenience sample of Peruvian older people. Subjects and methods: This was a cross-sectional study in 104 Geriatric Day Hospital patients in Lima, Perú. The ACE polymorphism was determined in all patients. For the purpose of association with age, the sample was divided into four categories: young (< 65), youngest-old (65–74), middle-old (75–84) and oldest-old (85 or more). Results: The distribution of genotype frequencies was consistent with a population in Hardy-Weinberg equilibrium (p = 0.62). The number (%) of D/D, I/D and I/I genotypes in the young was 2 (14.3%), 3 (21.4%) and 9 (64.3%), respectively; in youngest-old: 4 (11.4%), 15 (42.9%) and 16 (45.7%); in middle-old: 6 (12.2%), 20 (40.8%) and 23 (46.9%); and in oldest-old: 0 (0.0%), 4 (66.7%) and 2 (33.3%). A chi-square analysis showed no significant differences in genotype distribution between age groups (p = 0.647). Conclusion: No significant age differences were found in the distribution of the ACE polymorphism in this sample. Further studies with greater statistical power are recommended.
Start page
309
End page
312
Volume
47
Issue
3
Language
English
OCDE Knowledge area
Genética humana
Scopus EID
2-s2.0-85083580937
PubMed ID
Source
Annals of Human Biology
ISSN of the container
03014460
Sponsor(s)
ESSALUD–‘Kaelin Award, Instituto de Evaluación e Investigación de Tecnologías de la Salud-IETSI’ [Code: 04-IETSI-ESSALUD-2016], Lima, Perú. Román Romero-Ortuno is funded by Science Foundation Ireland under the President of Ireland Future Research Leaders programme [18/FRL/6188].
Sources of information: Directorio de Producción Científica Scopus